FDA label
What is Veltassa used for?
Veltassa contains patiromer. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Veltassa is indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Veltassa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Veltassa, powder, for suspension
Indications and Usage, quoted from the label by Vifor Pharma, Inc. (NDA205739). Cross-references to other label sections are left out.
Veltassa is indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older.
Limitation of Use: Veltassa should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action.
Source: DailyMed label, set id bf002984-d6c9-46df-aecb-a07733f763c1, version 23, effective January 31, 2025. NDC 53436-010, one of 4 listings for this product.
Questions
What is Veltassa used for?
The FDA label says: “Veltassa is indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older.”
What drug class is Veltassa?
FDA lists patiromer in the Potassium Binder established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.